See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Social Media
Stock Markets
Tariffs
Artificial Intelligence
US Economy
European Union
Baseball
NCAA
Donald Trump
Trade War
Aviation
Published • loading... • Updated

Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer

  • Harbour BioMed appointed Michael D. Patten as Chief Strategy Officer on March 10, 2025.
  • Michael D. Patten will report directly to Dr. Jingsong Wang, the CEO of Harbour BioMed.
  • Patten will oversee the company's global corporate development and grow its strategic partner network.
  • Dr. Jingsong Wang expressed confidence in Michael's ability to enhance the company's global presence.
Insights by Ground AI
Does this summary seem wrong?

48 Articles

All
Left
3
Center
14
Right
5
Rutland HeraldRutland Herald
+47 Reposted by 47 other sources

Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, today announced the appointment of…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 64% of the sources are Center
64% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Sentinel broke the news in Carlisle, United States on Tuesday, March 11, 2025.
Sources are mostly out of (0)

Similar News Topics

Rotterdam, South Holland

Rotterdam, South Holland

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal